The Sun Will Shine On Moderna Again - Initiating With A Buy [Seeking Alpha]
Moderna, Inc. (MRNA)
Last moderna, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
marinabio.com/investor-relations
Company Research
Source: Seeking Alpha
mNEXSPIKE approvals, flu and combo vaccines, and mRNA therapeutics expansion underpin Moderna's growth prospects for the coming years. Revenue declines are slowing, cost controls are effective, and losses are narrowing, with 2026 guidance targeting up to 10% revenue growth. Valuation remains attractive with a P/B discount to the sector, despite ongoing U.S. regulatory and legal risks. carmengabriela/iStock Editorial via Getty Images Moderna, Inc. ( MRNA ) was one of the biggest names of the COVID era as their SpikeVax vaccine was considered one of the most effective along with Pfizer ( PFE ) and BioNTech's ( This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business rel
Show less
Read more
Impact Snapshot
Event Time:
MRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRNA alerts
High impacting Moderna, Inc. news events
Weekly update
A roundup of the hottest topics
MRNA
News
- Is BioNTech SE (BNTX) A Good Stock To Buy Now? [Yahoo! Finance]Yahoo! Finance
- Moderna (MRNA) Climbs 16% as Arbutus-Genevant Legal Battle Clears [Yahoo! Finance]Yahoo! Finance
- Is Moderna Stock Outperforming the Dow? [Yahoo! Finance]Yahoo! Finance
- Why Moderna's $950M Patent Bill Is A Small Price For Pipeline Freedom [Seeking Alpha]Seeking Alpha
- Moderna to pay up to $2.25B to settle COVID vaccine patent matter [Yahoo! Finance]Yahoo! Finance
MRNA
Earnings
- 2/13/26 - Beat
MRNA
Sec Filings
- 3/5/26 - Form 8-K
- 3/3/26 - Form 4
- 3/3/26 - Form 4
- MRNA's page on the SEC website